RxDoctor Payments Data

James Spadaro

Interventional Cardiology · Rolla, MONPI 1063411999

Payments from drug & device makers

$1,166in general payments, 2019–2025

Across 67 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$184
  • Amarin Pharma, Inc.$168
  • E.r. Squibb & Sons, L.L.C.$115
  • Boehringer Ingelheim$88
  • Amgen$68
  • Philips North America LLC$67
  • plus $477 from 14 others

What the payments were for

  • Food & beverage$1,166100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,166 in reported general payments places this provider in the 5th percentile of 182 interventional cardiology providers in Missouri.

See all interventional cardiology providers in Missouri

Other interventional cardiology in Rolla

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →